Title(s):
EAZ171. Prospective validation trial of taxane therapy (docetaxel or weekly paclitaxel) and risk of chemotherapy-induced peripheral neuropathy in African American women
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s):
Alliance A221702. ARM: Axillary Reverse Mapping- A Prospective Trial to Study Rates of Lymphedema and Regional Recurrence after Sentinel Lymph Node Biopsy and Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Dissection With and Without Axillary Reverse Mapping
Investigator(s): Andrew Fenton, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s):
CCTG MA.39. A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Investigator(s): Mitchel Fromm, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s):
CTSU A011202. A Randomized Phase III Trial Evaluating the Role of Axillary Lymph Node Dissection in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Investigator(s):
Esther Rehmus, MD
Contact Information:
McDowell Cancer Research at 330.344.6348

Title(s):
NRG-BR002. A Phase IIR/III Trial of Standard of Care with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Investigator(s): Mitchell Fromm, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s):
17013. Mammaprint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene Expression Profiles: An Adaptable Registry (FLEX Registry)
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s):
SWOG 1501. Prospective evaluation of carvedilol in prevention of cardiac toxicity in patients with metastatic HER2 + breast cancer, phase III
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s):
19022 A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast Conserving Therapy
Investigator(s): Camille Berriochoa, MD
Contact Information: McDowell Cancer Research at 330.344.6348

Title(s):
NRG-BR007. A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score ≤18 Breast Cancer
Investigator(s): Ashok Ramalingam, MD
Contact Information: McDowell Cancer Research at 330.344.6348